Bank of New York Mellon Corp Sells 28,514 Shares of The Cooper Companies, Inc. $COO

Bank of New York Mellon Corp lessened its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,099,345 shares of the medical device company’s stock after selling 28,514 shares during the quarter. Bank of New York Mellon Corp’s holdings in Cooper Companies were worth $78,603,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after purchasing an additional 7,363 shares during the period. First Trust Advisors LP increased its stake in Cooper Companies by 115.8% during the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after purchasing an additional 73,165 shares in the last quarter. Cresset Asset Management LLC acquired a new stake in Cooper Companies during the 2nd quarter worth approximately $291,000. Cerity Partners LLC raised its holdings in Cooper Companies by 4.4% during the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after buying an additional 757 shares during the period. Finally, Daiwa Securities Group Inc. lifted its stake in Cooper Companies by 2.8% in the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after buying an additional 973 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

COO has been the subject of several research analyst reports. Wells Fargo & Company reiterated a “sell” rating and issued a $66.00 price target (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the stock an “overweight” rating in a report on Monday, June 1st. The Goldman Sachs Group set a $61.00 price objective on shares of Cooper Companies in a research report on Wednesday, May 27th. Citigroup reaffirmed a “neutral” rating and issued a $76.00 target price (up from $69.00) on shares of Cooper Companies in a research note on Wednesday, July 8th. Finally, Stifel Nicolaus lowered their target price on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $81.85.

Cooper Companies Stock Down 0.8%

COO stock opened at $71.01 on Wednesday. The company has a market cap of $13.85 billion, a price-to-earnings ratio of 60.18, a P/E/G ratio of 1.87 and a beta of 0.84. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The business has a 50 day moving average price of $66.71 and a two-hundred day moving average price of $72.36. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.During the same quarter in the prior year, the business posted $0.96 EPS. The business’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.